|
|
| | 2-((2,4-DiMethylphenyl)thio)phenylaMine Basic information |
| Product Name: | 2-((2,4-DiMethylphenyl)thio)phenylaMine | | Synonyms: | Wortioxetine intermediate: 2-((2,4-dimethylphenyl) thio) aniline;2-((2,4-DiMethylphenyl)thio)phenylaMine;2-[(2,4-diMethylphenyl)thio]-BenzenaMine;VOR-IM B;VOR-IM D;2-((2,4-dimethylphenyl)thio)aniline;Vortioxetine Impurity 60;Benzenamine, 2-[(2,4-dimethylphenyl)thio]- | | CAS: | 1019453-85-0 | | MF: | C14H15NS | | MW: | 229.34 | | EINECS: | | | Product Categories: | | | Mol File: | 1019453-85-0.mol |  |
| | 2-((2,4-DiMethylphenyl)thio)phenylaMine Chemical Properties |
| Boiling point | 341.3±30.0 °C(Predicted) | | density | 1.14±0.1 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C | | solubility | DMSO (Sparingly), Methanol (Sparingly) | | form | Oil to Semi-Solid | | pka | 3.12±0.10(Predicted) | | color | Dark Brown to Very Dark Red | | Stability: | Hygroscopic |
| | 2-((2,4-DiMethylphenyl)thio)phenylaMine Usage And Synthesis |
| Uses | 2-[(2,4-Dimethylphenyl)sulfanyl]aniline is used in the study of N-O-glucuronide metabolites of Lu AA21004 (Vortioxetine [V766000]), an antidepressant. | | Synthesis | Using 4-iodo-m- dimethylbenzene (1.43 mL, 10.0 mmol) and 2-aminothiophenol (1.07 mL, 10.0 mmol) as raw materials, the above raw materials were mixed with cuprous iodide (0.19 g, 1.0 mmol), potassium carbonate (6.90 g, 50.0 mmol) and dried and degassed dimethylsulfoxide (50 mL) under nitrogen protection at 120 °C for 16 h with stirring. After completion of the reaction, the mixture was cooled to room temperature, diluted with water (50 mL) and the product was extracted with ethyl acetate (2 x 150 mL). The organic layers were combined and washed sequentially with water (3 x 150 mL) and brine (3 x 150 mL). The organic phase was dried over anhydrous magnesium sulfate and the solvent was concentrated under reduced pressure to afford 2-((2,4-dimethylphenyl)thio)aniline as a dark colored oil (2.15 g, 94% yield). The structure of the product was confirmed by nuclear magnetic resonance hydrogen spectroscopy (1H NMR, CDCl3, 500 MHz) and mass spectrometry (ESI): 1H NMR δ 2.28 (s, 3H), 2.40 (s, 3H), 4.24 (br s, 2H), 6.71 (d, J = 8.1 Hz, 1H), 6.75-6.81 (m, 2H), 6.87 (m, 1H) 7.02 (m, 1H), 7.23 (m, 1H), 7.38 (dd, J = 1.5, 7.7 Hz, 1H); MS (ESI) m/z: 230 [MH]+. | | References | [1] Patent: WO2015/155153, 2015, A1. Location in patent: Page/Page column 15 |
| | 2-((2,4-DiMethylphenyl)thio)phenylaMine Preparation Products And Raw materials |
|